Aselsan’s 4Q19 net profit came in at TRY1.4b, higher than our estimate of TRY1.2b and the RT consensus of TRY1.1b. The deviation in the bottom-line came from higher-than-expected operating profitability. 4Q19 EBITDA of TRY1.3b came in 26% higher than our estimate of TRY1b and RT consensus of TRY1.1b.
Based on a lower risk-free rate assumption of 13% (previously 17%) and updated macro forecasts, we raise our DCF-based 12M TP (based on 2019 financials) by c10%, which implies a c10% upside potential. Despite being optimistic of the company’s operational performance, we believe the current risk/reward profile warrants a HOLD rating.
TEB Investment equity research analysts and strategist team consists of 8 analysts with an average finance sector experience of 15 years and special focus on international investors.
With our 6 equity research analysts we cover 93 companies across 21 sectors, reflecting 80% of the total market capitalization of all BIST companies and 86% of the BIST100 companies. Our strategy team provides in depth top-down and bottom-up market views with insight on FX and bond markets by publishing sectoral and strategic reports both in English and Turkish.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.